Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.32
Aug. 29, 2025 16:00:00- Change -0.009 (-2.73141%)
- Volume 682,036
- Today's Open 0.3276
- Previous Close 0.3295
- Today's High 0.3276
- Today's Low 0.3171
- 52 Week High 4.3
- 52 Week Low 0.313